Drug induced immune haemolytic anaemia in the Berlin Case‐Control Surveillance Study
Edeltraut Garbe(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Hanife Kurtal(Charité - Universitätsmedizin Berlin), Martin Hildebrandt(Humboldt-Universität zu Berlin), Andreas Grüneisen(Vivantes Klinikum), Frank Andersohn(Charité - Universitätsmedizin Berlin), E. Späth‐Schwalbe(Vivantes Klinikum), Hubert Schrezenmeier(German Red Cross), Andreas Klimpel(Charité - Universitätsmedizin Berlin), Abdulgabar Salama(Charité - Universitätsmedizin Berlin), Beate Mayer(Charité - Universitätsmedizin Berlin), Michael Thomae, Elisabeth Bronder(Charité - Universitätsmedizin Berlin)
Cited by 99
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|653